CY1110087T1 - Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο - Google Patents

Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο

Info

Publication number
CY1110087T1
CY1110087T1 CY20101100451T CY101100451T CY1110087T1 CY 1110087 T1 CY1110087 T1 CY 1110087T1 CY 20101100451 T CY20101100451 T CY 20101100451T CY 101100451 T CY101100451 T CY 101100451T CY 1110087 T1 CY1110087 T1 CY 1110087T1
Authority
CY
Cyprus
Prior art keywords
byr
methods
compounds containing
preparing compounds
disorders
Prior art date
Application number
CY20101100451T
Other languages
English (en)
Inventor
Xiaohu Deng
Jimmy T Liang
Neelakandha Mani
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1110087T1 publication Critical patent/CY1110087T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η παρούσα εφεύρεση κατευθύνεται προς νέες μεθόδους παρασκευής συμπυκνωμένων πυρραζολικών ενώσεων, χρήσιμων για τη θεραπεία διαταραχών και καταστάσεων όπου μεσολαβεί δράσει υποδοχέα σεροτονίνης (Ι).
CY20101100451T 2006-05-05 2010-05-21 Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο CY1110087T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74649706P 2006-05-05 2006-05-05
EP07761874A EP2016064B1 (en) 2006-05-05 2007-05-04 Methods for the preparation of pyrazole-containing compounds

Publications (1)

Publication Number Publication Date
CY1110087T1 true CY1110087T1 (el) 2015-01-14

Family

ID=38566748

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100451T CY1110087T1 (el) 2006-05-05 2010-05-21 Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο

Country Status (12)

Country Link
US (1) US7915404B2 (el)
EP (1) EP2016064B1 (el)
CN (1) CN101479252B (el)
AT (1) ATE459614T1 (el)
CY (1) CY1110087T1 (el)
DE (1) DE602007005117D1 (el)
DK (1) DK2016064T3 (el)
ES (1) ES2340217T3 (el)
PL (1) PL2016064T3 (el)
PT (1) PT2016064E (el)
SI (1) SI2016064T1 (el)
WO (1) WO2007131153A2 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2009058810A1 (en) * 2007-11-02 2009-05-07 Janssen Pharmaceutica N.V. Process for the preparation of substituted 2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene derivatives
US8309578B2 (en) * 2008-11-25 2012-11-13 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272866A1 (en) * 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
ES2319539T3 (es) 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators

Also Published As

Publication number Publication date
CN101479252B (zh) 2014-01-29
US7915404B2 (en) 2011-03-29
PL2016064T3 (pl) 2010-08-31
EP2016064B1 (en) 2010-03-03
US20070260057A1 (en) 2007-11-08
DK2016064T3 (da) 2010-06-07
WO2007131153A3 (en) 2008-01-10
ES2340217T3 (es) 2010-05-31
CN101479252A (zh) 2009-07-08
EP2016064A2 (en) 2009-01-21
ATE459614T1 (de) 2010-03-15
WO2007131153A2 (en) 2007-11-15
SI2016064T1 (sl) 2010-07-30
PT2016064E (pt) 2010-04-16
DE602007005117D1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
EA200701588A1 (ru) Способы получения замещённых фенилпиразолмочевин
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
IN2014KN00929A (el)
DE602005021696D1 (de) Indazolcarbonsäureamidverbindungen
EA201071057A1 (ru) Производные азетидина и циклобутана как ингибиторы jak-киназ
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
EA200600049A1 (ru) Способы получения 3 - бензазепинов
EA200970583A1 (ru) Способ получения пиперазиниловых и диазепаниловых производных бензамида
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
EA201190158A1 (ru) Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
DE602006019595D1 (de) Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors
MX348451B (es) Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparación y su uso como antagonistas p2y12.
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique
EA200701867A1 (ru) Хинолиноновые соединения в качестве агонистов рецептора 5-ht
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
CY1110087T1 (el) Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο
EA200801240A1 (ru) Новые способы получения производных циклопропиламида
EA201391710A1 (ru) Замещенные производные индола для лечения иммунологических расстройств
EA200801239A1 (ru) Новые способы получения пиперазинильных и диазепанильных производных бензамина
EA200802000A1 (ru) Фармацевтически приемлемые соли и полиморфные формы
SG178990A1 (en) Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
TW200716602A (en) Novel compounds